My ePortfolio Register   
The First Targeted Personalised Cancer Medicines

The First Targeted Personalised Cancer Medicines

en English

Only available as part of a course
Proceed to module  Shortlist  Rate Module  Share
Language

en English

Summary A short lecture on the First Targeted Personalised Cancer Medicines
Description

Prof Gordon McVie of European Institute of Oncology in Milan, Italy gives a short lecture on First Targeted Personalised Cancer Medicines.

THIS E-LEARNING MODULE RUNS BEST ON MOZILLA FIREFOX AND INTERNET EXPLORER 7 AND ABOVE WITH FLASH ENABLED.

Target Audience

Healthcare professionals and researchers wishing to expand on their knowledge of Personalised Medicine.

Learning Objectives

By the end of this module, you should be able to:

  • Understand what oncogenes are in the context of the genome.
  • Understand the role of targeted cancer therapies in tumour growth.
  • Realise why targeted therapies are only appropriate for certain oncogenes.
  • Learn the different types of targeted therapies.
  • Recognise the challenge of personalised medicine in this context.
Only available as part of course(s):

Personalised Medicine

IT Requirements

This module requires the learner to have a good, stable internet connection and runs best on INTERNET EXPLORER 7 AND ABOVE, and MOZILLA FIREFOX on either Windows or MacOS. FLASH ADD ON is also required to run this module.

Proceed to Module

Relevant to the following professions

  • Nurse
  • Oncologist
  • Other
  • Public Health
  • Researcher
Proceed to module  Shortlist  Rate Module


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence